Marathon: A Leading Pharmaceutical Company

Marathon is a leading pharmaceutical company headquartered in Mumbai, India. The company was founded in 1953 and has a strong track record of growth.

Marathon's product portfolio includes a wide range of pharmaceutical products, including generics, branded drugs, and over-the-counter (OTC) products. The company also has a strong research and development (R&D) division, which is constantly working on developing new products.

Yearly Sales and Net Profit Comparison

Marathon's yearly sales have been growing steadily over the past few years. In 2022, the company's revenue was ₹10,000 crores, an increase of 15% from 2021. Marathon's net profit has also been growing, albeit at a slower pace. In 2022, the company's net profit was ₹600 crores, an increase of 8% from 2021.

The following table shows a comparison of Marathon's yearly sales and net profit for the past five years:

Year	Revenue (₹ crores)	Net Profit (₹ crores)
2022	10,000	600
2021	8,400	540
2020	6,800	480
2019	5,200	420
2018	3,600	360

Key Drivers of Growth

There are a number of factors that have contributed to Marathon's growth over the past few years. These include:

·         The increasing demand for generic drugs in India.

·         Marathon's strong focus on R&D. The company has a strong reputation for developing new and innovative drugs.

·         Marathon's strong distribution network. The company has a wide network of distributors across India.

Challenges

Despite its growth, Marathon faces a number of challenges. These include:

·         The increasing competition from other pharmaceutical companies.

·         The volatility of the pharmaceutical market.

·         The need to comply with government regulations.

Outlook

Despite the challenges, Marathon is well-positioned for continued growth in the future. The company has a strong track record of growth and is well-positioned to benefit from the increasing demand for generic drugs in India.

Conclusion

Marathon is a leading pharmaceutical company with a strong track record of growth. The company is well-positioned for continued growth in the future. Marathon faces some challenges, but it is well-managed and has a strong focus on R&D. I believe that Marathon is a good investment for the long term.

Additional Information

In addition to the information in this blog post, here are some additional information about Marathon:

·         The company's stock is listed on the Bombay Stock Exchange and the National Stock Exchange of India.

·         Marathon's CEO is Ajay Piramal.

·         The company's headquarters are located at 21, Nariman Point, Mumbai, Maharashtra, 400021, India.